Wednesday's pre-market session: top gainers and losers
By Mill Chart
Last update: Apr 24, 2024
Stay updated with the stocks that are on the move in Wednesday's pre-market session.
Pre-market gainers
| Ticker | Change | Comment |
|---|---|---|
| CSSE | 86.15% | Exciting news for CHICKEN SOUP FOR THE SOUL EN (NASDAQ:CSSE) as their shares soared 86.15% to $0.28 during the pre-market session on Wednesday. The stock is trading 56.71% lower than 6 months ago. |
| RILY | 30.29% | B. RILEY FINANCIAL INC's (NASDAQ:RILY) shares rose 30.29% to $28.3. NASDAQ:RILY is releasing earnings today. Shareholders saw the stock price going 39.65% lower is the past 6 months. |
| PEB | 22.98% | Exciting news for PEBBLEBROOK HOTEL TRUST (NYSE:PEB) as their shares soared 22.98% to $19.0 during the pre-market session on Wednesday. Yesterday the company had a press release: Pebblebrook Hotel Trust Reports First Quarter 2024 Results. |
| SOUNW | 21.14% | SOUNDHOUND AI INC (NASDAQ:SOUNW) rose 21.14% to $2.12 during Wednesday's pre-market session. Today's pre-market session shows a continuation of the previous session's success for NASDAQ:SOUNW, with a 21.14% increase following yesterday's 37.8% gain. |
| TPET | 20.8% | Exciting news for TRIO PETROLEUM CORP (NYSEARCA:TPET) as their shares soared 20.8% to $0.43 during the pre-market session on Wednesday. Shareholders saw the stock price going 282.0% higher in the past month. |
| WIMI | 18.56% | During Wednesday's pre-market trading, WIMI HOLOGRAM CLOUD INC-ADR (NASDAQ:WIMI) demonstrated strong momentum, with the stock price rising 18.56% to $0.86. In the last month the stock lost 23.19%. |
| VRT | 17.47% | VERTIV HOLDINGS CO-A (NYSE:VRT) experienced an impressive 17.47% increase in share price, reaching $93.0 during the pre-market session on Wednesday. yesterday the company released their earnings. Earlier today the company had a press release: Vertiv Reports 60% Organic Orders Growth, 8% Net Sales Growth in First Quarter; Updates Full Year 2024 Outlook. |
| AEYE | 16.47% | AUDIOEYE INC's (NASDAQ:AEYE) shares rose 16.47% to $15.7. Also in the previous session NASDAQ:AEYE had a very good day: shares closed with a 13.76% gain. |
| IMMP | 15.54% | Pre-market trading on Wednesday showed positive momentum for IMMUTEP LTD-SP ADR (NASDAQ:IMMP), as the stock price advanced 15.54% to reach $2.9. The stock is trading 34.22% higher than 6 months ago. |
| AZ | 15.04% | During Wednesday's pre-market trading, A2Z SMART TECHNOLOGIES CORP (NASDAQ:AZ) demonstrated strong momentum, with the stock price rising 15.04% to $0.52. Today's pre-market session builds upon the previous day's success, as NASDAQ:AZ continues its upward trajectory following a 12.82% gain. |
For the full premarket gainers list go to our premarket gainers page.
Pre-market losers
| Ticker | Change | Comment |
|---|---|---|
| DCFC | -62.91% | Investors observed a 62.91% decline in TRITIUM DCFC LTD's (NASDAQ:DCFC) stock price, which now stands at $1.35 during Wednesday's pre-market session. Shareholders saw the stock price going 73.62% lower in the past month. |
| FN | -24.46% | FABRINET's (NYSE:FN) shares experienced a 24.46% decline, falling to $127.42 during Wednesday's pre-market session. Two days ago the company had a press release: Fabrinet to Announce Third Quarter Fiscal Year 2024 Financial Results on May 6, 2024. |
| LUCY | -17.29% | Wednesday's pre-market session showed a 17.29% decrease in the stock price of INNOVATIVE EYEWEAR INC (NASDAQ:LUCY), reaching $0.21. In the last 3 months the stock lost 39.59%. |
| OVID | -15.31% | The stock price of OVID THERAPEUTICS INC (NASDAQ:OVID) is declining by 15.31%, reaching $2.71 during Wednesday's pre-market session. |
| NKGN | -13.51% | NKGEN BIOTECH INC's (NASDAQ:NKGN) shares experienced a 13.51% decline, falling to $1.6 during Wednesday's pre-market session. Following an impressive 25.85% run-up in yesterday's session, NASDAQ:NKGN experiences a pullback in today's pre-market session, showcasing the market's dynamic nature. |
| CSLR | -13.51% | Despite yesterday's decline, COMPLETE SOLARIA INC (NASDAQ:CSLR) experienced a further 13.51% decrease in share price during Wednesday's pre-market session, reaching $0.37. Prices are quite volatile now: this is a reversal from yesterday's 10.51% gain. |
| OST | -13.4% | Today's pre-market session reveals a 13.4% decline in the stock price of OSTIN TECHNOLOGY GROUP CO LT (NASDAQ:OST), now priced at $0.43. After a strong performance yesterday with a 25.0% gain, NASDAQ:OST shows signs of retracement with a 13.4% decline in today's pre-market session. |
| HWH | -13.25% | During Wednesday's pre-market session, the shares of HWH INTERNATIONAL INC (NASDAQ:HWH) declined by 13.25%, reaching $1.31. The current market conditions exhibit high volatility as NASDAQ:HWH retraces its steps after yesterday's 17.97% gain. |
| KPRX | -12.96% | KIORA PHARMACEUTICALS INC's (NASDAQ:KPRX) shares fell 12.96% to $0.5 during Wednesday's pre-market session. Yesterday's 19.48% gain in NASDAQ:KPRX gives way to a 12.96% decrease in today's pre-market session, showcasing market fluctuations. |
| APDN | -10.45% | The stock price of APPLIED DNA SCIENCES INC (NASDAQ:APDN) is declining by 10.45%, reaching $0.26 during Wednesday's pre-market session. The downward trend from yesterday's -12.12% drop persisted in today's pre-market session, with another decline of 10.45% for NASDAQ:APDN. |
For the full premarket loser list go to our premarket losers page.
NKGEN BIOTECH INC
NASDAQ:NKGN (5/17/2024, 7:16:11 PM)
After market: 1.1 -0.02 (-1.79%)1.12
-0.01 (-0.88%)
NKGN News
SANTA ANA, Calif., May 16, 2024 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (Nasdaq: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company...
In vitro studies with SNK01 have shown a direct ability to phagocytose and digest amyloid and alpha-synuclein proteins while also secreting...
SANTA ANA, Calif., April 24, 2024 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (Nasdaq: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology...
NKGen Biotech Inc (NASDAQ:NKGN) shares traded higher on Monday, with a strong session volume of 19.25 million, compared to an average 100-day volume of 2.85 million, according to data from Benzinga Pro. However, there is no news to justify the +20% increase in the stock price. NKGen Biotech will present details about its NK cell therapy for neurodegenerative disease, review its preclinical data for Parkinson’s disease, and highlight clinical safety and efficacy data from the recently completed P
SANTA ANA, Calif., April 18, 2024 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (Nasdaq: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology...
a month ago - InvestorPlaceNKGN Stock Earnings: NKGen Biotech Reported Results for Q4 2023NKGen Biotech just reported results for the fourth quarter of 2023.
The Company’s neurodegenerative clinical program remains on track, with continued advancement of the Alzheimer’s Phase 2 trial and anticipation of...
SNK01 autologous NK cell therapy demonstrated a positive effect on cerebral spinal fluid (“CSF”) and plasma Tau proteins in Alzheimer’s patients. The...
